• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species.

作者信息

Houston A K, Jones R N

机构信息

Medical Microbiology Division, University of Iowa College of Medicine, Iowa City 52242.

出版信息

J Chemother. 1994 Feb;6(1):12-4. doi: 10.1080/1120009x.1994.11741121.

DOI:10.1080/1120009x.1994.11741121
PMID:8071670
Abstract

The in-vitro post-antibiotic effect (PAE) was determined for two newer beta-lactams, FK-037 (a cephalosporin) and biapenem (a carbapenem). Our PAE results for these drugs were consistent with what has been reported previously for similar beta-lactams, e.g. Gram-positive organisms had measurable effects (0.4-2.2 hours), while Gram-negatives had variable results (0.0 to 1.4 hours). Even though the PAE test conditions generally coincided with achievable clinical levels for most organisms tested (< or = 4 mg/L for biapenem and < or = 8 mg/L for FK-037), the marginal or species dependent, short PAE values support the selection of multiple daily doses (two-to-four) based on conventional pharmacokinetic parameters such as the Cmax, AUC, and serum elimination half-life.

摘要

相似文献

1
Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species.
J Chemother. 1994 Feb;6(1):12-4. doi: 10.1080/1120009x.1994.11741121.
2
Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.
J Antimicrob Chemother. 1996 Dec;38(6):1055-60. doi: 10.1093/jac/38.6.1055.
3
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].[2004年抗微生物药物对从尿路感染患者分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 2006 Jun;59(3):177-200.
4
Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation.基于群体药代动力学/药效学建模和蒙特卡罗模拟的中国下呼吸道感染患者比阿培南的最佳剂量方案。
Int J Antimicrob Agents. 2016 Mar;47(3):202-9. doi: 10.1016/j.ijantimicag.2015.12.018. Epub 2016 Jan 30.
5
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms.亚胺培南对革兰氏阳性和革兰氏阴性微生物的抗生素后效应。
J Antimicrob Chemother. 1986 Dec;18 Suppl E:47-59. doi: 10.1093/jac/18.supplement_e.47.
6
Control-related effective regrowth time and post-antibiotic effect of meropenem on gram-negative bacteria studied by bioluminescence and viable counts.通过生物发光和活菌计数研究美罗培南对革兰氏阴性菌的与控制相关的有效再生长时间及抗生素后效应。
J Antimicrob Chemother. 1995 May;35(5):585-92. doi: 10.1093/jac/35.5.585.
7
Bactericidal activity of ertapenem against major intra-abdominal pathogens.厄他培南对主要腹腔内病原体的杀菌活性。
Int J Antimicrob Agents. 2006 Nov;28(5):396-401. doi: 10.1016/j.ijantimicag.2006.07.018. Epub 2006 Oct 11.
8
Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.新型广谱头孢菌素FK-037的抗菌活性。与头孢吡肟和头孢他啶的国际体外比较。
Diagn Microbiol Infect Dis. 1994 Mar;18(3):167-73. doi: 10.1016/0732-8893(94)90087-6.
9
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.使用各种美国国家临床实验室标准委员会药敏试验方法时,比阿培南、DU-6859a、FK-037、左氧氟沙星、格帕沙星和头孢唑肟的最低抑菌浓度质量控制指南。质量控制研究小组。
Diagn Microbiol Infect Dis. 1994 May;19(1):65-8. doi: 10.1016/0732-8893(94)90054-x.
10
In vitro antibacterial activities of FK037: a new parenteral cephalosporin.新型胃肠外给药头孢菌素FK037的体外抗菌活性
Chemotherapy. 1995 Jul-Aug;41(4):257-66. doi: 10.1159/000239354.

引用本文的文献

1
Biapenem.比阿培南
Drugs. 2002;62(15):2221-34; discussion 2235. doi: 10.2165/00003495-200262150-00005.
2
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.